{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:54:24Z","timestamp":1787162064292,"version":"build-2736575974"},"reference-count":50,"publisher":"Baishideng Publishing Group Inc.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Gastroenterol"],"abstract":"BACKGROUND<\/jats:p>\n Incomplete resection of rectal neuroendocrine tumors (NETs), defined by positive or indeterminate margins or lymphovascular invasion, raises concerns regarding residual disease and recurrence. However, the benefits of salvage treatment in these cases remain unclear.<\/jats:p>\n AIM<\/jats:p>\n To evaluate the oncologic impact of salvage treatment compared with observation after incomplete endoscopic resection of rectal NETs through a systematic review and meta-analysis.<\/jats:p>\n METHODS<\/jats:p>\n We conducted a systematic review and meta-analysis in accordance with the preferred reporting items for systematic reviews and meta-analyses guidelines. MEDLINE, EMBASE, and the Cochrane Library were searched from their inception until May 2025. Eligible studies included patients with incompletely resected rectal NETs managed with salvage treatment or observation, reporting outcomes of residual tumors or recurrence. Pooled estimates were calculated using random-effects models with Hartung-Knapp adjustments.<\/jats:p>\n RESULTS<\/jats:p>\n Thirty-four studies with 2279 cases of incomplete endoscopic resection met the inclusion criteria. The incomplete resection rates differed markedly according to the initial resection method (17 studies): 73.1% for cold snare polypectomy, 29.8% for conventional endoscopic mucosal resection (EMR), 28.4% for modified EMR, and 14.7% for endoscopic submucosal dissection. Among the 19 studies that evaluated salvage treatment, the pooled residual tumor rate was 25.0% [95% confidence interval (CI): 12.0%-40.0%]. The crude recurrence rates from 31 studies favored salvage treatment over observation (0.96% vs 2.96%, P = 0.003). However, a meta-analysis of nine comparative studies found no statistically significant difference in recurrence risk (odds ratio = 0.89; 95%CI: 0.40-2.02).<\/jats:p>\n CONCLUSION<\/jats:p>\n Given the relatively high residual tumor rate and low incidence of recurrence, salvage treatment may be justified as both a diagnostic and therapeutic approach after incomplete resection of rectal NETs. Although its benefits in preventing recurrence remain unclear, clinical decisions should be individualized, as these findings are based on low-certainty evidence.<\/jats:p>","DOI":"10.3748\/wjg.v32.i3.113452","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:28:27Z","timestamp":1768523307000},"source":"Crossref","is-referenced-by-count":3,"title":["Is salvage treatment necessary after incomplete resection of rectal neuroendocrine tumors: A systematic review and meta-analysis"],"prefix":"10.3748","volume":"32","author":[{"given":"Jae Hyun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Min","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seun Ja","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13309"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(07)70410-2"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-021-01827-7"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.4377"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.0589"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1079575"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/deo2.163"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.5946\/ce.2012.45.1.89"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.5946\/ce.2022.115"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000001914"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1177\/00031348241226722"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-023-09999-4"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-022-09710-z"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.267"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2023.12.015"},{"key":"B16","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practive Guidelines in Oncology. Neuroendocrine and Adrenal Tumors. ver 1.2025"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39489.470347.AD"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-022-02365-z"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-40668-6"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2024.04.1584"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000002516"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv234.06"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-017-5497-x"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15231"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13092535"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2024.108651"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-014-3555-1"},{"key":"B29","unstructured":"Hwang J, Park Y, Yoon H, Shin C, Kim N, Lee D. Clinico-pathologic characteristics that affect the treatment and recurrence of rectal carcinoid tumour in Korea. Abstracts of the 10th Scientific and Annual Meeting of the European Society of Coloproctology; 2015 Sep 23-25; Dublin, Ireland. Colorectal Dis 2015; 68"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2013.03.1316"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2010.12.029"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4174\/astr.2024.107.3.151"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2016.1216591"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1344860"},{"key":"B35","unstructured":"Kim S, Koh SJ, Im JP, Kim JS, Lee HJ. Long-Term Clinical Outcomes of Microscopic Incomplete Resection after Macroscopic Complete Endoscopic Resection in Rectal Neuroendocrine Tumors. Gut Liver 2024; 97"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-024-10963-z"},{"key":"B37","unstructured":"Kim YJ, Lee SK, Cheon JH, Kim TI, Lee YC, Kim WH, Chung JB, Yi SW, Park S. [Efficacy of endoscopic resection for small rectal carcinoid: a retrospective study]. Korean J Gastroenterol 2008; 174-180"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2024.04.2722"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2024.2340008"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S332838"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1089\/lap.2011.0068"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2015.1107752"},{"key":"B43","unstructured":"Oh HH, Kim DH, Lim KY, Ji JH, Choi S, Lee JG, Jung Y, Chun J, Joo YE. Factors Associated Remnant Tumor after Incompletely Resected Rectal Neuroendocrine Tumor: A KASID Multicenter Study. Gut Liver 2024; 18"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2025.03.023"},{"key":"B45","unstructured":"Seo Y, Joo YE, Oh HH, Lim CJ, Kim JS, Im CM, Kim S. Clinical Outcomes of Endoscopic Incompletely Resected Rectal Neuroendocrine Tumors and Risk Factors Associated with Residual Tumors after Salvage Treatment. Gut Liver 2024"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e3283551e0b"},{"key":"B47","unstructured":"Takita M, Ohata K, Misumi Y, Tsunashima H, Tashima T, Minato Y, Sakai E, Muramoto T, Matsuyama Y, Nonaka K, Matuhashi N. Clinical outcomes of rectal neuroendocrine tumors treated by endoscopic resection. United Eur Gastroent J 2015; A454"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2020.02.25"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.21037\/jgo-21-391"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1093\/gastro\/goac084"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/1007-9327\/full\/v32\/i3\/113452.htm","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.wjgnet.com\/1007-9327\/full\/v32\/i3\/113452.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:28:50Z","timestamp":1768523330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/1007-9327\/full\/v32\/i3\/113452.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":50,"journal-issue":{"issue":"3"},"alternative-id":["113452"],"URL":"https:\/\/doi.org\/10.3748\/wjg.v32.i3.113452","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,21]]}}}